Grail (GRAL) Change in Receivables (2023 - 2026)
Grail's (GRAL) quarterly Change in Receivables came in at -$204000.0 in Q2 2026, up 92.86% on a YoY basis from -$105776.4 in Q2 2025, and down 108.88% quarter-over-quarter from $2.3 million in Q1 2026.
Analysis
Grail (GRAL) Change in Receivables (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Change in Receivables for 4 consecutive years, with -$204000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Receivables rose 92.86% year-over-year to -$204000.0; the trailing twelve-month figure through Jun 2026 stood at $4.0 million (up 20.37% YoY), and the FY2025 full-year result was -$1.7 million, down 150.0% from the prior year.
- Change in Receivables slipped to -$204000.0 in Q2 2026 per GRAL's latest filing, from $2.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $7.4 million in Q4 2023 and bottomed at -$2.9 million in Q2 2025.
- Historically, Change in Receivables has averaged $786166.7 across 4 years, with a median of -$64500.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Change in Receivables plunged 95.84% in 2025, then jumped 414.66% in 2026.
- Over 4 years, Change in Receivables stood at $7.4 million in 2023, then tumbled by 31.45% to $5.1 million in 2024, then plunged by 64.18% to $1.8 million in 2025, then tumbled by 111.17% to -$204000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$204000.0, $2.3 million, and $1.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 4.37 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 79.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 59.20 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 6.89 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 52.56 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 26.37 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 14.15 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 13.59 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 1.20 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -204,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -204,000.00 |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | -2.86 Mn |
| Mar 31, 2025 | -730,000.00 |
| Dec 31, 2024 | 5.10 Mn |
| Sep 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | -1.62 Mn |
| Mar 31, 2024 | -1.91 Mn |
| Dec 31, 2023 | 7.44 Mn |
| Oct 1, 2023 | -1.79 Mn |